首页> 新闻动态> 易特科集团与嘉盛集团签约雾化器项目战略合作

易特科集团与嘉盛集团签约雾化器项目战略合作

2021-06-11 11:04

2021年6月10日,深圳市易特科投资控股有限公司与湖南嘉盛电陶新材料股份有限公司在深圳国际创新谷签署了“电子烟雾化器项目”的战略合作备忘录,双方本着“资源整合、优势互补、共赢发展”的原则,将在“电子烟雾化器”领域展开全面深入合作,重点面向美国市场的电子烟雾化器(Vaporizer烟具)、日本市场加热不燃烧电子烟烟具和烟弹(HNB Iqos 和 E-Pipe),携手共同进行相关产品的研发及市场拓展。易特科集团董事长兼CEO张贯京先生、副董事长兼CFO肖应芬女士、联合创始人兼CTO葛新科博士、执行总裁康萌女士、战略合作业务总监赵立先生、技术研发总监苏超英先生、投资副总监彭凌霖先生等核心团队,与到访的嘉盛集团联合创始人邓朝辉先生、嘉盛集团副总裁邱业欢先生、嘉盛智因大健康科技总经理章雪丽女士、嘉盛智因大健康科技常务副总经理李宜疆先生、奥楚科技总经理陈楚辉先生等管理团队共同见证了这一时刻!



嘉盛电陶新材料股份有限公司成立于2004年,是一家在雾化科技领域的领先企业,公司先后与湖南大学、中国地质大学、武汉理工大学、北京工业大学、国防科大等大专院校合作,长期聘请相关专家教授作为技术顾问。同时组建并培养了一支经验丰富的工程技术经营团队。公司目前核心产品为低膨胀系数电子结构陶瓷,主要领域为家电、新型烟草、医疗器械产品的核心部件。掌握全球唯一的脂溶性超声雾化技术以及新一代加热陶瓷雾化技术,主要涉及应用于新型烟草与大健康领域的雾化核芯及各领域雾化应用的电子设备。公司下设8家子公司,依托母公司嘉盛电陶的技术优势,围绕超声雾化技术,聚焦大健康和新型烟草领域,为各产业客户提供全球领先的多样性雾化解决方案。




易特科投控(安测健康)聚焦医疗信息化及医疗智能化,持续创新产品,升级了智慧健康全流程管理系统、智慧医养管理平台、智慧医院云信息系统、智慧影像辅助判读平台和智慧中医辅助辨识平台五大核心产品线,产品结构不断优化,技术优势日益凸显!


在各界朋友的合作支持下,易特科投控(安测健康)不断加强关键核心技术攻关;作为华为全球生态合作伙伴,AI慢病管理系统入选华为云严选方案,鲲鹏云ARM架构,ISV;与清华大学签署智慧医疗研发创新战略合作协议;安测肺病医疗影像辅助诊断系统正多家综合医院进行合作研究,未来将全面推动我国肺癌精准医学事业发展;全力推进“大湾区中医科学院”建设,由院士牵头,以国医大师和科学家为核心团队,会聚国内著名中医科研院所及信息科技公司,以生命科学、信息科技、人工智能为手段,探索人体生理病理、规范中医诊断标准、提升中医诊疗水平,将创新科技融入中医,让现代中医走向世界!

凭借在“AI+医疗、AI+健康、AI+养老”领域的高科技产品、人工智能技术、知识产权创新、产业化优势和近三年营收规模复合高速增长,易特科投控(安测健康)荣获德勤中国主办评选的2020“中国高科技高成长企业50强”与“深圳高科技高成长企业20强”、招商证券的“羚跃计划”、招商银行“新动能基金”重点推荐企业、国家知识产权优势企业、深圳质量百强企业、两项技术获第21届中国专利优秀奖,累计获得6项中国专利优秀奖,知识产权总量超过3100项、AI慢病管理系统荣获深圳市科技进步二等奖……安测健康产品创新、技术创新和知识产权创新实力获得社会各界认可,创新实力在智慧医疗领域全国领先!目前安测健康产品及服务已进入全国650多家公立医疗机构和450多家社康中心,产品竞争力、产品成熟度、市场接受度、品牌影响力、议价能力等方面均显著提升!



基于易特科投控在医疗科技领域有深厚技术积累并且是一个高度国际化的公司,而且在日本和美国拥有电子烟(雾化器)领域的专业渠道和投资商伙伴;湖南嘉盛公司在电子烟雾化器领域拥有深厚技术积淀和实力,为此合作双方为布局海外电子烟领域,开展电子烟相关业务,进行了深度的资源整合,实现优势互补,建立起稳固、多维度的战略合作伙伴关系,进一步做大做强美国和日本电子烟市场的供应链,为海外合作伙伴做好技术和产品支撑。



On June 10, 2021, E-techco Group and Hunan Jiasheng Diantao New Materials Co., Ltd. signed a strategic cooperation memorandum on "Vaporizer Project" in Shenzhen International Innovation Valley. Based on the principle of "resource integration, complementary advantages and win-win development", the two sides will carry out comprehensive and in-depth cooperation in the field of "Vaporizer", Focus on the U.S. market, and HNB iqos  for the Japanese market.Two parites will work together to develop related products and expand the market. Mr. Zhang guanjing, Chairman and CEO of E-techco Group, Ms. Kang Meng, CEO, Ms. Xiao Yingfen, vice chairman and CFO, Dr. Ge Xinke, co-founder and CTO, Mr. Zhao Li, director of strategic cooperation business, Mr. Su Chaoying, director of technical research and development, , Mr. Peng Linglin, deputy director of investment and other core teams, have witnessed this moment together with the visiting management teams, including Mr. Deng Chaohui, co-founder of Jiasheng Group, Mr. Qiu yehuan, vice president of Jiasheng Group, Ms. Zhang Xueli, general manager of Jiasheng Zhiyin Health Technology, Mr. Li Yijiang, executive deputy general manager of Jiasheng Zhiyin Health Technology, and Mr. Chen Chuhui, general manager of Aochu Technology!

Jiasheng Diantao New Material Co., Ltd., founded in 2004, is a leading enterprise in the field of atomization technology. The company has cooperated with Hunan University, China University of Geosciences, Shanghai Institute of Silicate, Chinese Academy of Sciences, Wuhan University of technology, Beijing University of technology, National Defense University and other colleges, and has long employed relevant experts and professors as technical consultants. At the same time, Jiasheng has established and trained an experienced engineering technology management team. At present, the company's core products are Low Expansion Coefficient Electronic Structural Ceramics, mainly in the fields of home appliances, new tobacco, and core components of medical devices. Jiasheng also masters the world's only Fat Soluble Ultrasonic Atomization technology and the new generation of Heated Ceramic Atomization technology, mainly involving the atomization core applied in the field of new tobacco and big health and electronic equipment applied in various fields. The company has eight subsidiaries, relying on the technical advantages of the parent company Jiasheng Group, focusing on the field of health industry and new tobacco around ultrasonic atomization technology, to provide global leading diversified atomization solutions for customers in various industries.


E-Techco Group(Anycheck)focusing on medical information and medical intelligence, it have continuously innovated products, upgraded five core product lines, including intelligent health full process management system, intelligent medical care management platform, intelligent hospital cloud information system, intelligent image assistant interpretation platform and intelligent TCM auxiliary identification platform. The product structure is constantly optimized and the technical advantages are increasingly prominent!

With the cooperation of friends from all walks of life, E-techco Group (Anycheck) has constantly strengthened key core technology to solve key problems; As Huawei global ecological partner, AI slow disease management system is selected as Huawei Cloud Strict Selection Scheme, Kunpeng cloud arm architecture, ISV; Signed strategic cooperation agreement with Tsinghua University on smart medical R & D innovation; The medical imaging assisted diagnosis system of lung disease is cooperating with many general hospitals, which will promote the development of precision medicine of lung cancer in China in the future; We will make every effort to promote the construction of "Dawan District Academy of Traditional Chinese Medicine", led by academicians, and take the national medical masters and scientists as the core team, and gather well-known Chinese medicine research institutes and information technology companies in China. With the means of life science, information technology and artificial intelligence, we will explore human physiology and pathology, standardize the diagnosis and treatment standards of traditional Chinese medicine, improve the level of TCM diagnosis and treatment, and integrate innovative technology into traditional Chinese medicine, Let modern Chinese medicine go to the world!
 
With the high-tech products, artificial intelligence technology, intellectual property innovation, industrialization advantages and the compound high-speed growth of revenue scale in the field of "AI+ medical, AI+ health and AI+ pension", E-Techco Group (Anycheck) won the 2020 "Top 50 High-tech and High-growth Enterprises of China" and "Top 20 High-tech and High-growth Enterprises in Shenzhen" sponsored by Deloitte China, The "Antelope Plan" of China Merchants Securities, key recommendation enterprises of "New Kinetic Energy Fund" of China Merchants Bank, “State-owned Enterprises with Intellectual Property Advantages”, “Top 100 Enterprises of Shenzhen Quality” and two technologies won the “21st China Patent Excellence Award”, and “6 Outstanding Chinese Patent awards” . With the total intellectual property rights exceeding 3100, its “AI Chronic Disease Management System” won the second prize of Shenzhen Science and technology progress. 

Anycheck product’s innovation, technology innovation and intellectual property innovation strength have been recognized by all walks of life in the society, and the innovation strength is the leading in the field of intelligent medical treatment in China! At present, Anycheck products and services have entered more than 650 public medical institutions and more than 450 social health centers in China. The competitiveness of products, product maturity, market acceptance, brand influence and bargaining power have been significantly improved! 

E-Techco Group has a deep technical accumulation in the field of medical technology and is a highly international company. It also has professional channels and investment partners in the field of electronic cigarette (Vaporizer) in Japan and the United States; Hunan Jiasheng Co., Ltd. has profound technical accumulation and strength in the field of Vaporizer. Therefore, in order to lay out the overseas e-cigarette field and carry out e-cigarette related business, the two sides have carried out in-depth resource integration, realized complementary advantages, established a solid and multi-dimensional strategic cooperative partnership, and further expanded and strengthened the supply chain of e-cigarette markets in the United States and Japan, Provide technical and product support for overseas partners.

按年份查询

全部

2021

2020

2019

2018

2017

2016

2015

2014

2013

搜索